GlaxoSmithKline CEO JP Garnier is grilled relentlessly by a BCC radio reporter about the suppression of data that suggested the anti-depressant Paxil (Seroxat in the U.K.) increased the likelihood of teen suicides — and finally walks out of the interview. Here’s the 10-minute clip; the meltdown starts at about the seven-minute mark:
More on the [...]
Tags: GlaxoSmithKline · Paxil · Seroxat
Sen. Charles Grassley, the ranking Republican on the Senate Finance Committee, says that the FDA’s Drug Safety Oversight Board voted 8-7 on Oct. 2 to keep the scandal-plagued diabetes drug Avandia on the market. The result was kept from the public.
Wow, what a nailbiter. That’s enough to give Glaxo execs a heart attack [...]
Tags: Avandia · GlaxoSmithKline
From HealthDay News:
The widely used but controversial diabetes drug Avandia will now have a strong “black box” warning on its label, advising users of an increased risk of heart failure, the U.S. Food and Drug Administration announced late Tuesday. Another four diabetes drugs from the same class, including Actos, will also carry a similar black-box [...]
Tags: Avandia · FDA · GlaxoSmithKline
Glaxo pulled a rabbit out of the hat in its earnings report today with a little misdirection. Per MarketWatch:
GlaxoSmithKline on Wednesday took some of the attention away from disappointing sales of diabetes drugs by announcing it was lifting its stock buyback authorization to 12 billion pounds ($24.7 billion).
Experts expected to see Glaxo report a [...]
[Read more →]
Tags: Avandia · Diabetes · GlaxoSmithKline
That’s my favorite line from the Mark Sisson’s Daily Apple post, “10 Great Alli Leaks, Oops, Links.” Check it out.
Tags: Alli · GlaxoSmithKline
The new diet drug Alli, produced by GlaxoSmithKline, is selling fast. As you’ve probably seen in the news, it’s the first FDA-approved OTC weight-loss pill.
What’s interesting to me is that Alli’s embarrassing side effects have done little to dissuade potential users from buying the product.
Glaxo says to expect “gas with oily spotting” [...]
Tags: Alli · GlaxoSmithKline
Although we already know why Avandia is still on the market, the FDA released the preliminary results of its evaluation of the GlaxoSmithKline drug. Here are the results via the Washington Post:
The government’s own preliminary evaluation of the diabetes pill Avandia confirms the heart risks reported in a study earlier this week and suggests that [...]
[Read more →]
Tags: Avandia · GlaxoSmithKline
On April 11, PBS plans to broadcast “Fat: What No One is Telling You” — a program sponsored by GlaxoSmithKline.
Jeff Chester, executive director of the Center for Digital Democracy, comments:
The drug giant just happens to have a recently approved for over-the-counter drug on the market — under the brand name Alli ™ [...]
Tags: Big Pharma · GlaxoSmithKline
rss feed
